BACKGROUND: Many institutions recommend a stepwise approach to intradermal testing for venom @entity566 . This is costly and uncomfortable for the @entity1 . The rationale for this approach is the risk of potential adverse reactions to testing with the maximal dose alone. OBJECTIVE: To evaluate the safety of a single-step approach to venom @entity566 testing. METHODS: The authors retrospectively reviewed the charts of 300 consecutive @entity1 with suspected hymenoptera venom @entity566 based on history who underwent venom @entity566 testing in a single allergist's clinic where a single-step protocol had been adopted. All @entity1 had positive skin test reaction to at least 1 hymenoptera venom. Charts were reviewed for testing protocol used, results of testing, and reported immediate and delayed adverse reactions to testing. RESULTS: All @entity1 underwent testing with an identical single-step protocol with an intradermal dose of 0.02 mL of a 1.0- g/mL concentration of each of the 5 commercially available vespid and @entity5157 venoms. Only 1 @entity1 reported an adverse reaction to testing, which was delayed until the morning after his visit. There were no immediate adverse reactions. The @entity1 who had the delayed reaction was successfully started on venom immunotherapy subsequent to his reaction. CONCLUSION: A single-step venom @entity566 intradermal testing protocol with a 1.0- g/mL concentration of commercially available extracts is a safe option, which, if adopted into practice, could lead to more streamlined care for @entity1 and cost savings for the medical system.

XXXX testing: is a graded approach necessary?

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity566 :: ('MESH:D006967', 'Disease') :: ['allergy'] @entity5157 :: ('7460', 'Species') :: ['bee']
@entity566 :: (MESH:D006967,Disease) :: ['Venom allergy']
